Diagnostic and management pathways for pulmonary carcinoid tumours in the United Kingdom: results from the National Lung Neuroendocrine Tumour Pathway Project
Affiliation
The Christie NHS Foundation Trust, Wilmslow Rd., Manchester M20 4BX, UK.Issue Date
2020
Metadata
Show full item recordCitation
Manoharan P, Lamarca A, Navalkissoor S, Calero J, Chan PS, Julyan P, et al. Safety, tolerability and clinical implementation of 'ready-to-use' (68)gallium-DOTA0-Tyr3-octreotide ((68)Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs). ESMO Open. 2020;5.Journal
International Journal of EndocrinologyDOI
10.1155/2020/9287536PubMed ID
32190050Additional Links
https://dx.doi.org/10.1155/2020/9287536Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1155/2020/9287536